Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
The purpose of this study is to learn if giving 17-hydroxyprogesterone caproate (17 OHPC) to mothers with preeclampsia diagnosed before 34 weeks gestation improves mother and baby outcomes.
UMMC antepartum patients with preterm PE between 23 0/7ths and 34 0/7ths weeks g... [+1]
>33 weeks gestational age or <23 weeks gestation [+14]